Primary antiphospholipid syndrome (PAPS) is a clotting disorder attributed to autoreactive antibodies produced by B cells. Here the authors show, using single cell omics and B cell repertoire data ...

Long COVID symptoms can persist for years, with slim chance of full recovery Funding and attention for long COVID research are dwindling in many wealthy ...

Objectives: This is a critical review of anti-phospholipid antibodies (aPL). Most prior reviews focus on the aPL syndrome (APS), a thrombotic condition often marked by neurological disturbance.

This includes HSV-1, the type most commonly linked to cold sores, and HSV-2, the type mainly associated with genital herpes. The test doesn't detect the virus itself but instead detects ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have ...

Background: Antiphospholipid antibodies (aPL) trigger inflammation, vasculopathy, and thrombosis, sharing pathophysiological mechanisms with atherosclerosis. However, their association with incident ...

Two common screening tests are: Antibody test: This is the most common type of HIV screening test. It doesn't look for the virus but instead looks for disease-fighting proteins (antibodies ...

HIV seroconversion, specifically, is the time from HIV exposure, to infection, and to developing antibodies that can be detected by a test. This can take a few weeks and is sometimes called the ...

New antibody could be promising cancer treatment Date: November 11, 2024 Source: Uppsala University Summary: Researchers have developed a new form of precision medicine, an antibody, with the ...

Most people with lupus have antinuclear antibodies (ANAs) in their blood. But a positive ANA test doesn’t always mean lupus. The test can be positive in people with other autoimmune illnesses — ...

Health departments in two states took blood tests of workers on dairy farms known to have hosted infected cattle and found that about 7 per cent of them have antibodies for the disease.